Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chantal Pharand

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Thrombosis Research|December 25, 2003
Platelet activity and antibody titers after exposure to streptokinase or streptococcal infectionMaryse Courval, Donald A Palisaitis, Jean G Diodati, et al.
International Journal of Cardiology|March 9, 2010
Heterogeneity in platelet cyclooxygenase inhibition by aspirin in coronary artery diseaseMarie Lordkipanidzé, Chantal Pharand, Erick Schampaert, et al.
Pharmacotherapy|May 28, 2004
Inhibition of streptokinase-induced, antibody-mediated platelet aggregation with tirofiban after exposure to streptokinase or streptococcal infectionMaryse Courval, Donald A Palisaitis, Jean G Diodati, et al.
Thrombosis Research|March 3, 2009
Evaluation of the platelet count drop method for assessment of platelet function in comparison with "gold standard" light transmission aggregometryMarie Lordkipanidzé, Chantal Pharand, Erick Schampaert, et al.
Thrombosis Research|May 8, 2009
Insights into the interpretation of light transmission aggregometry for evaluation of platelet aggregation inhibition by clopidogrelMarie Lordkipanidzé, Chantal Pharand, Donald A Palisaitis, et al.
Therapeutic Drug Monitoring|June 4, 2008
Assessment of VerifyNow P2Y12 assay accuracy in evaluating clopidogrel-induced platelet inhibitionMarie Lordkipanidzé, Chantal Pharand, Thuy Anh Nguyen, et al.
The Canadian Journal of Cardiology|August 14, 2003
Distinction between myocardial ischemia and postural changes in continuous ECG monitoring based on ST-segment amplitude and vector orientation--preliminary resultsChantal Pharand, James B Nasmith, Jean-Claude Rajaonah, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|December 27, 2005
Absence of clinically significant increase in pulmonary artery pressure after intravenous perflutren injection for myocardial perfusion imaging in pigsMarilyn de Chantal, Robert Amyot, Jean G Diodati, et al.
Thrombosis Research|March 25, 2011
Genetic determinants of response to aspirin: appraisal of 4 candidate genesMarie Lordkipanidzé, Jean G Diodati, Donald A Palisaitis, et al.
Thrombosis and Haemostasis|August 5, 2009
Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2)Normand Blais, Chantal Pharand, Marie Lordkipanidzé, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Thrombosis Research|December 25, 2003
Platelet activity and antibody titers after exposure to streptokinase or streptococcal infectionMaryse Courval, Donald A Palisaitis, Jean G Diodati, et al.
International Journal of Cardiology|March 9, 2010
Heterogeneity in platelet cyclooxygenase inhibition by aspirin in coronary artery diseaseMarie Lordkipanidzé, Chantal Pharand, Erick Schampaert, et al.
Pharmacotherapy|May 28, 2004
Inhibition of streptokinase-induced, antibody-mediated platelet aggregation with tirofiban after exposure to streptokinase or streptococcal infectionMaryse Courval, Donald A Palisaitis, Jean G Diodati, et al.
Thrombosis Research|March 3, 2009
Evaluation of the platelet count drop method for assessment of platelet function in comparison with "gold standard" light transmission aggregometryMarie Lordkipanidzé, Chantal Pharand, Erick Schampaert, et al.
Thrombosis Research|May 8, 2009
Insights into the interpretation of light transmission aggregometry for evaluation of platelet aggregation inhibition by clopidogrelMarie Lordkipanidzé, Chantal Pharand, Donald A Palisaitis, et al.
Therapeutic Drug Monitoring|June 4, 2008
Assessment of VerifyNow P2Y12 assay accuracy in evaluating clopidogrel-induced platelet inhibitionMarie Lordkipanidzé, Chantal Pharand, Thuy Anh Nguyen, et al.
The Canadian Journal of Cardiology|August 14, 2003
Distinction between myocardial ischemia and postural changes in continuous ECG monitoring based on ST-segment amplitude and vector orientation--preliminary resultsChantal Pharand, James B Nasmith, Jean-Claude Rajaonah, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|December 27, 2005
Absence of clinically significant increase in pulmonary artery pressure after intravenous perflutren injection for myocardial perfusion imaging in pigsMarilyn de Chantal, Robert Amyot, Jean G Diodati, et al.
Thrombosis Research|March 25, 2011
Genetic determinants of response to aspirin: appraisal of 4 candidate genesMarie Lordkipanidzé, Jean G Diodati, Donald A Palisaitis, et al.
Thrombosis and Haemostasis|August 5, 2009
Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2)Normand Blais, Chantal Pharand, Marie Lordkipanidzé, et al.
Pageof 3